Related Experiment Video
Updated: Jul 26, 2026

10:03
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Research and development of unconventional systems for immunization
Summary
Global population growth necessitates controlling microbial and parasitic infections threatening protein sources. The U.S. Agency for International Development (USAID) employs immunization and genetic strategies, with pilot studies exploring novel application systems.
Area of Science:
- Public Health
- Microbiology
- Parasitology
Background:
- Expanding global populations increase pressure on protein resources.
- Microbial and parasitic infections pose a significant threat to food security and protein sources.
- Effective control strategies are crucial for sustainable development and public health.
Purpose of the Study:
- To outline the importance of controlling microbial and parasitic infections for global protein sources.
- To describe the U.S. Agency for International Development's (USAID) program for infection control.
- To highlight innovative approaches in infection control, including pilot studies.
Main Methods:
- Utilizing immunization programs to prevent infections.
- Employing bacterial and viral genetics to develop attenuated strains for vaccines.
- Improving the production, preservation, and distribution of medical preparations.
- Conducting pilot studies to test novel application systems in specific regions.
Main Results:
- The program aims to mitigate the impact of infections on protein sources.
- Genetic engineering techniques are used to create safer and more effective microbial agents.
- Enhanced logistical strategies ensure wider accessibility of control preparations.
- Pilot studies are evaluating the efficacy of unconventional application methods.
Conclusions:
- Continued development and efficient operation of infection control methods are vital.
- USAID's multifaceted approach addresses critical public health challenges.
- Innovative application systems show promise for future public health interventions.
Related Concept Videos
Vaccinations
Overview
Active versus Passive Immunity
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Active Immunity
Active immunity refers to the resistance one develops...
Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Vaccines
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

